LPL Financial LLC Has $2.05 Million Stock Position in DaVita Inc. (NYSE:DVA)

LPL Financial LLC trimmed its holdings in DaVita Inc. (NYSE:DVA - Free Report) by 26.1% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 13,721 shares of the company's stock after selling 4,836 shares during the period. LPL Financial LLC's holdings in DaVita were worth $2,052,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. Del Sette Capital Management LLC acquired a new stake in DaVita in the 4th quarter worth approximately $1,254,000. KLP Kapitalforvaltning AS acquired a new stake in shares of DaVita in the fourth quarter worth $4,234,000. Sei Investments Co. boosted its holdings in shares of DaVita by 212.6% during the 4th quarter. Sei Investments Co. now owns 90,769 shares of the company's stock worth $13,578,000 after buying an additional 61,731 shares during the period. TD Private Client Wealth LLC lifted its position in DaVita by 1,483.8% during the 4th quarter. TD Private Client Wealth LLC now owns 4,688 shares of the company's stock worth $701,000 after acquiring an additional 4,392 shares during the last quarter. Finally, Kiker Wealth Management LLC bought a new stake in DaVita during the fourth quarter valued at about $818,000. Institutional investors own 90.12% of the company's stock.

DaVita Trading Down 0.9 %

NYSE:DVA traded down $1.29 during trading hours on Friday, hitting $140.21. 994,193 shares of the stock were exchanged, compared to its average volume of 834,677. The company's 50 day moving average is $149.13 and its two-hundred day moving average is $156.00. The company has a market capitalization of $11.22 billion, a P/E ratio of 13.05, a price-to-earnings-growth ratio of 1.07 and a beta of 1.04. DaVita Inc. has a twelve month low of $128.69 and a twelve month high of $179.60. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18.

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. On average, sell-side analysts anticipate that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on DVA. Barclays raised their target price on DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a report on Tuesday, February 18th. Cowen restated a "hold" rating on shares of DaVita in a report on Tuesday, February 18th. StockNews.com upgraded shares of DaVita from a "hold" rating to a "buy" rating in a research note on Thursday, April 10th. Finally, Sanford C. Bernstein set a $184.00 price objective on DaVita in a research report on Friday, February 21st. One analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat.com, DaVita currently has an average rating of "Hold" and a consensus target price of $166.33.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.